Details for New Drug Application (NDA): 211918
✉ Email this page to a colleague
The generic ingredient in METHYLPHENIDATE HYDROCHLORIDE is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
Summary for 211918
Tradename: | METHYLPHENIDATE HYDROCHLORIDE |
Applicant: | Andor Pharms |
Ingredient: | methylphenidate hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 18MG | ||||
Approval Date: | Apr 24, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 27MG | ||||
Approval Date: | Apr 24, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 36MG | ||||
Approval Date: | Apr 24, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription